DIN 00894745 — CLOZARIL 100 MG
CLOZARIL is a tablet of Clozapine marketed by HLS THERAPEUTICS INC. The full Clozapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00894745
- Brand name
- CLOZARIL
- Active ingredient
- Clozapine
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- HLS THERAPEUTICS INC
- Health Canada status
- MARKETED
- Drug class
- Atypical (second-generation) antipsychotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Clozapine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02248035 | AA-CLOZAPINE | 100 MG | TABLET | AA PHARMA INC | MARKETED |
| 02458756 | AA-CLOZAPINE | 200 MG | TABLET | AA PHARMA INC | MARKETED |
| 02248034 | AA-CLOZAPINE | 25 MG | TABLET | AA PHARMA INC | MARKETED |
| 02458748 | AA-CLOZAPINE | 50 MG | TABLET | AA PHARMA INC | MARKETED |
| 02490676 | CLOZARIL | 200 MG | TABLET | HLS THERAPEUTICS INC | MARKETED |
| 00894737 | CLOZARIL | 25 MG | TABLET | HLS THERAPEUTICS INC | MARKETED |
| 02490668 | CLOZARIL | 50 MG | TABLET | HLS THERAPEUTICS INC | MARKETED |
| 02247244 | GEN-CLOZAPINE | 100 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02554674 | GEN-CLOZAPINE | 100 MG | TABLET (ORALLY-DISINTEGRATING) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02554631 | GEN-CLOZAPINE | 12.5 MG | TABLET (ORALLY-DISINTEGRATING) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02305011 | GEN-CLOZAPINE | 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02554682 | GEN-CLOZAPINE | 200 MG | TABLET (ORALLY-DISINTEGRATING) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02247243 | GEN-CLOZAPINE | 25 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02554658 | GEN-CLOZAPINE | 25 MG | TABLET (ORALLY-DISINTEGRATING) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02305003 | GEN-CLOZAPINE | 50 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02554666 | GEN-CLOZAPINE | 50 MG | TABLET (ORALLY-DISINTEGRATING) | MYLAN PHARMACEUTICALS ULC | MARKETED |